Risk factors for breast cancer from benign breast disease in a diverse population Maria J. WorshamUsha RajuSandra R. Wolman Preclinical Study 04 October 2008 Pages: 1 - 7
Intraductal approach to the detection of intraductal lesions of the breast Tadaharu MatsunagaTakeharu MisakaMasahiko Fujii Preclinical Study 10 October 2008 Pages: 9 - 13
Biological significance of allele specific loss of the p53 gene in breast carcinomas Pia P. WegmanNashwan J. MarcusSten Wingren Preclinical Study 14 October 2008 Pages: 15 - 20
Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab Erin M. GoldblattPriscilla A. EricksonBrittney-Shea Herbert Preclinical study 14 October 2008 Pages: 21 - 32
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis Zengshan LiLatonya CarrierBrian G. Rowan Preclinical Study 15 October 2008 Pages: 33 - 43
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy Katja SpechtNadia HarbeckHeinz Hoefler Preclinical study 17 October 2008 Pages: 45 - 56
The prognostic impact of occult nodal metastasis in early breast carcinoma Daehoon ParkRolf KåresenTorill Sauer Cinical Trial 15 February 2009 Pages: 57 - 66
Differentiation of benign and malignant breast lesions by mechanical imaging Vladimir EgorovThomas KearneyArmen Sarvazyan Clinical trial 21 March 2009 Pages: 67 - 80
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study Georgiana K. EllisHenry G. BoneDennis Kim Clinical Trial 24 March 2009 Pages: 81 - 87
Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer Hyo Song KimYeon Hee ParkYoung-Hyuck Im Clinical trial 26 March 2009 Pages: 89 - 97
Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention Julia H. RowlandBeth E. MeyerowitzPatricia A. Ganz Clinical trial 24 April 2009 Pages: 99 - 111
MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells Shawn P. FesslerMark T. WotkowiczCynthia Bamdad Preclinical study 05 May 2009 Pages: 113 - 124
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users Monique J. BijlRon H. N. van SchaikLoes E. Visser Epidemiology 03 February 2009 Pages: 125 - 130
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers Sharon Nofech-MozesMaureen TrudeauWedad M. Hanna Epidemiology 03 February 2009 Pages: 131 - 137
Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population Hae Won ShinDong Young NohYoung Ho Yun Epidemiology 04 February 2009 Pages: 139 - 150
A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer Juan Manuel Rosa-RosaGuillermo PitaJavier Benitez Epidemiology 10 February 2009 Pages: 151 - 159
Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast DeShawn TaylorCeleste Leigh PearceDebra Hawes Epidemiology 10 February 2009 Pages: 161 - 168
A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women Zhanwei WangYan XuHongbing Shen Epidemiology 10 February 2009 Pages: 169 - 175
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists Alice J. SigurdsonParveen BhattiJeffery P. Struewing Epidemiology 12 February 2009 Pages: 177 - 184
Expression profile of microRNAs in c-Myc induced mouse mammary tumors Yuan SunJack WuD. Joshua Liao Brief Report 07 September 2008 Pages: 185 - 196
Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells Hongjie PanLuke S. WanamiRobin E. Bachelder Brief Report 12 September 2008 Pages: 197 - 205
A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer Natalia BogdanovaCezary CybulskiThilo Dörk Brief Report 21 September 2008 Pages: 207 - 211
Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth Triparna Ghosh-ChoudhuryChandi C. MandalNandini Ghosh-Choudhury Brief Report 26 October 2008 Pages: 213 - 228